FDA Import Refusal 112-7129690-1/1/3 — Boehringer Ingelheim Canada

Boehringer Ingelheim Canada — FEI 3001645453

The FDA refused shipment 112-7129690-1/1/3 from Boehringer Ingelheim Canada (Canada) on Jun 11, 2012. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Jun 11, 2012
Country
Canada
Product Category
Drugs and Biologics
Product Code
62OCA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.